Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Walter R Bosch

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
International Journal of Radiation Oncology, Biology, Physics|July 6, 2010
Late rectal toxicity on RTOG 94-06: analysis using a mixture Lyman modelSusan L Tucker, Lei Dong, Walter R Bosch, et al.
International Journal of Radiation Oncology, Biology, Physics|January 2, 2009
Elective clinical target volumes for conformal therapy in anorectal cancer: a radiation therapy oncology group consensus panel contouring atlasRobert J Myerson, Michael C Garofalo, Issam El Naqa, et al.
International Journal of Radiation Oncology, Biology, Physics|July 26, 2024
NRG Oncology White Paper on the Relative Biological Effectiveness in Proton TherapyHarald Paganetti, Charles B Simone, Walter R Bosch, et al.
Journal of Neuro-Oncology|March 20, 2019
NRG brain tumor specialists consensus guidelines for glioblastoma contouringTim J Kruser, Walter R Bosch, Shahed N Badiyan, et al.
Cancer|April 8, 2015
Preliminary patient-reported outcomes analysis of 3-dimensional radiation therapy versus intensity-modulated radiation therapy on the high-dose arm of the Radiation Therapy Oncology Group (RTOG) 0126 prostate cancer trialDeborah W Bruner, Daniel Hunt, Jeff M Michalski, et al.
Cancer|April 8, 2015
NRG Oncology/RTOG 0921: A phase 2 study of postoperative intensity-modulated radiotherapy with concurrent cisplatin and bevacizumab followed by carboplatin and paclitaxel for patients with endometrial cancerAkila N Viswanathan, Jennifer Moughan, Brigitte E Miller, et al.
International Journal of Radiation Oncology, Biology, Physics|April 28, 2009
Development of RTOG consensus guidelines for the definition of the clinical target volume for postoperative conformal radiation therapy for prostate cancerJeff M Michalski, Colleen Lawton, Issam El Naqa, et al.
International Journal of Radiation Oncology, Biology, Physics|June 28, 2014
Interobserver variability in target definition for hepatocellular carcinoma with and without portal vein thrombus: radiation therapy oncology group consensus guidelinesTheodore S Hong, Walter R Bosch, Sunil Krishnan, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 13, 2014
Radiation therapy quality assurance in clinical trials--Global Harmonisation GroupChristos Melidis, Walter R Bosch, Joanna Izewska, et al.
Frontiers in Oncology|March 20, 2013
Future vision for the quality assurance of oncology clinical trialsThomas J Fitzgerald, Maryann Bishop-Jodoin, Walter R Bosch, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
International Journal of Radiation Oncology, Biology, Physics|July 6, 2010
Late rectal toxicity on RTOG 94-06: analysis using a mixture Lyman modelSusan L Tucker, Lei Dong, Walter R Bosch, et al.
International Journal of Radiation Oncology, Biology, Physics|January 2, 2009
Elective clinical target volumes for conformal therapy in anorectal cancer: a radiation therapy oncology group consensus panel contouring atlasRobert J Myerson, Michael C Garofalo, Issam El Naqa, et al.
International Journal of Radiation Oncology, Biology, Physics|July 26, 2024
NRG Oncology White Paper on the Relative Biological Effectiveness in Proton TherapyHarald Paganetti, Charles B Simone, Walter R Bosch, et al.
Journal of Neuro-Oncology|March 20, 2019
NRG brain tumor specialists consensus guidelines for glioblastoma contouringTim J Kruser, Walter R Bosch, Shahed N Badiyan, et al.
Cancer|April 8, 2015
Preliminary patient-reported outcomes analysis of 3-dimensional radiation therapy versus intensity-modulated radiation therapy on the high-dose arm of the Radiation Therapy Oncology Group (RTOG) 0126 prostate cancer trialDeborah W Bruner, Daniel Hunt, Jeff M Michalski, et al.
Cancer|April 8, 2015
NRG Oncology/RTOG 0921: A phase 2 study of postoperative intensity-modulated radiotherapy with concurrent cisplatin and bevacizumab followed by carboplatin and paclitaxel for patients with endometrial cancerAkila N Viswanathan, Jennifer Moughan, Brigitte E Miller, et al.
International Journal of Radiation Oncology, Biology, Physics|April 28, 2009
Development of RTOG consensus guidelines for the definition of the clinical target volume for postoperative conformal radiation therapy for prostate cancerJeff M Michalski, Colleen Lawton, Issam El Naqa, et al.
International Journal of Radiation Oncology, Biology, Physics|June 28, 2014
Interobserver variability in target definition for hepatocellular carcinoma with and without portal vein thrombus: radiation therapy oncology group consensus guidelinesTheodore S Hong, Walter R Bosch, Sunil Krishnan, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 13, 2014
Radiation therapy quality assurance in clinical trials--Global Harmonisation GroupChristos Melidis, Walter R Bosch, Joanna Izewska, et al.
Frontiers in Oncology|March 20, 2013
Future vision for the quality assurance of oncology clinical trialsThomas J Fitzgerald, Maryann Bishop-Jodoin, Walter R Bosch, et al.
Pageof 4